| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |